DiagnoCure’s one, two punch against cancer
November 24, 2009 by leonardzehr · Leave a Comment
There is much talk these days about personalized medicine, but John Schafer likes to call it personal diagnostics. “I’m not trying to use my (molecular) test to make a drug, although you can and pharmaceutical companies are doing that,” the CEO of DiagnoCure (TSX:CUR) says in an exclusive interview with biotuesdays.com. “What I am using [...]
Listen to BioTuesdays 
